US Stock MarketDetailed Quotes

SBFM Sunshine Biopharma

Watchlist
  • 2.7500
  • +0.0400+1.48%
Close Dec 13 16:00 ET
  • 2.6501
  • -0.0999-3.63%
Post 20:01 ET
5.50MMarket Cap-0.02P/E (TTM)

Sunshine Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sunshine Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 12.500M--
--2024/Q38.435M / 11.800M--
--2024/Q29.303M / 9.000M--
--2024/Q17.541M / 7.000M--
--2023/Q47.680M / 6.100M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 12.500M--
--2024/Q38.435M / 11.800M--
--2024/Q29.303M / 9.000M--
--2024/Q17.541M / 7.000M--
--2023/Q47.680M / 6.100M--

Unlock Free Earnings Estimates

Sunshine Biopharma Earnings Reports

  • 8-K: SUNSHINE BIOPHARMA REPORTS 2024 THIRD QUARTER RESULTS: YEAR-TO-DATE REVENUES UP 54%

    Nov 7 16:48 ET

  • 10-Q: Q3 2024 Earnings Report

    Nov 5 16:06 ET

  • 10-Q/A: Quarterly report (Amendment)

    Aug 20 16:09 ET

  • 8-K: SUNSHINE BIOPHARMA REPORTS 2024 SECOND QUARTER RESULTS: SECOND QTR REVENUES UP 67%, YTD REVENUES UP 61%

    Aug 19 16:09 ET

    • Read more

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data